Celcuity Inc. SEC filings CELC
Celcuity Inc. has 541 filings in SEC EDGAR's recent list, going back to Mar 24, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 305B2 | Filing | Jun 5, 2026 | — |
| D/A | Filing | Sep 23, 2025 | — |
| 305B2 | Filing | Jul 31, 2025 | — |
| EFFECT | Filing | Dec 2, 2024 | — |
| CORRESP | Letter to the SEC | Nov 27, 2024 | — |
| D/A | Filing | Oct 15, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2024 | — |
| D/A | Filing | Jun 28, 2024 | — |
| D/A | Filing | Apr 25, 2024 | — |
| EFFECT | Filing | Nov 28, 2023 | — |
| D/A | Filing | Nov 27, 2023 | — |
| D/A | Filing | Nov 27, 2023 | — |
| CORRESP | Letter to the SEC | Nov 24, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| D | Filing | Oct 26, 2023 | — |
| D/A | Filing | May 2, 2023 | — |
| EFFECT | Filing | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2023 | — |
| D/A | Filing | Nov 28, 2022 | — |
| D/A | Filing | Nov 28, 2022 | — |
| D | Filing | May 26, 2022 | — |
| D/A | Filing | Apr 8, 2022 | — |
| EFFECT | Filing | Nov 26, 2021 | — |
| CORRESP | Letter to the SEC | Nov 23, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2021 | — |
| D/A | Filing | Nov 22, 2021 | — |
| D/A | Filing | Nov 22, 2021 | — |
| D | Filing | Apr 14, 2021 | — |
| D | Filing | Apr 14, 2021 | — |
| EFFECT | Filing | Apr 5, 2021 | — |
| CORRESP | Letter to the SEC | Mar 31, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2021 | — |
| D/A | Filing | Nov 2, 2020 | — |
| D/A | Filing | Nov 2, 2020 | — |
| D/A | Filing | Oct 31, 2019 | — |
| D/A | Filing | Oct 31, 2019 | — |
| D/A | Filing | Nov 7, 2018 | — |
| D/A | Filing | Nov 7, 2018 | — |
| EFFECT | Filing | Oct 4, 2018 | — |
| D/A | Filing | Nov 7, 2017 | — |
| D/A | Filing | Nov 7, 2017 | — |
| EFFECT | Filing | Sep 19, 2017 | — |
| CERTNAS | Auto-generated paper document | Sep 19, 2017 | — |
| CORRESP | Letter to the SEC | Sep 18, 2017 | — |
| CORRESP | Letter to the SEC | Sep 18, 2017 | — |
| 8-A12B | Form 8-a12b | Sep 15, 2017 | — |
| CORRESP | Letter to the SEC | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Sep 5, 2017 | — |
| CORRESP | Letter to the SEC | Sep 1, 2017 | — |
| CORRESP | Letter to the SEC | Aug 31, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2017 | — |
| DRSLTR | Filing | Aug 14, 2017 | — |
| DRS/A | Filing | Aug 14, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2017 | — |
| DRSLTR | Filing | Jul 14, 2017 | — |
| DRS/A | Filing | Jul 14, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2017 | — |
| DRS | Filing | Jun 12, 2017 | — |
| D | Filing | May 19, 2017 | — |
| D | Filing | May 2, 2017 | — |
| D | Filing | Feb 26, 2016 | — |
| D/A | Filing | Feb 26, 2016 | — |
| D | Filing | Dec 18, 2015 | — |
| D | Filing | Mar 24, 2014 | — |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CELC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1603454
- Former names
- Celcuity LLC (until Sep 15, 2017)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.